Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Celera Genomics (CRA) -- Ignore unavailable to you. Want to Upgrade?

To: GlobalMarine who wrote (325)	5/9/2000 9:53:00 AM
From: gao seng	Read Replies (1) \| Respond to of 746

Today, the international public consortium also announced it has completed--almost--"phase one" of the entire human genome project, the rough draft of the human genome. (About 85% of the promised 90% of the draft sequence is now available in Genbank.) The consortium says it's now ready to enter "phase two" and turn its collective sequencing firepower to finishing the human genome--that is, producing the 99.99% accurate sequence that has now been reached for chromosome 21 and 22. The consortium's announcement came on the eve of an annual genome meeting at Cold Spring Harbor Laboratory--and some wonder if it was designed to preempt an expected statement from Celera Genomics in Rockville, Maryland, the international consortium's big rival. Today, Celera head J. Craig Venter praised the chromosome 21 data, but dismissed the other announcement as an "artificial" milestone and "science by press release"--a practice in which his opponents say Venter is well schooled. sciencenow.sciencemag.org If that link doesn't work, this one should: academicpress.com